Searched for
PLASMID DNA PLATFORM
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- Pharma stocks: Time to change the prescription? 13 pharma stocks with an upside potential of up to 39%Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the fact is that th...
- With the tariff threat headache over, time to focus on them again? 8 pharma stocks with upside potential of up to 39%With a clear indication that no additional or special tariff will be imposed by the US on generic drugs, there is a sense of relief among I...
- Best way to deal with volatility, just “ Hold” for wealth creation: 7 large-cap stocks with an upside potential of up to 41%If you are a long-term investor, your decisions cannot be based on what the Nifty or Sensex do every week, or even every quarter. So, if yo...
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
- Sectoral tailwinds and stronger balance sheets: 5 largecap stocks with right mix of two important ratiosThere are some sectors where large players have an edge, because the nature of the business is such that there are phases where ability to ...
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Cadila's Covid vax to be introduced in 7 states firstThe Indian government will initially introduce Cadila Healthcare's Covid-19 vaccine ZyCoV-D in seven states, including Maharashtra and West...
- India first to develop DNA vaccine, can be administered to 12 and above: PM Narendra Modi"India, which lives on Sewa Paramo Dharma (service is the main duty), is engaged in vaccination development and manufacturing despite limit...
- Zydus Cadila now plans to test its Covid-19 vaccine for 5-12 age groupThe pharma major has already covered 800-plus children in 12-18 years clinical trials.
- The 2-billion Vaccine Question: How realistic are estimates and what's the current status?The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trial...
- Cadila Healthcare Working on Needle-free, 2-Dose VaccineThe drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...
- View: How to battle a pandemic? Valuable lessons from IndiaAbout 10 million of such cases were predicted to happen within a 2-3 weeks window, resulting in hospitalisations overwhelming our hospitals...
- Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19 vaccineThe Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...
- Zydus Cadila to apply for Phase-3 trials in December, hopes to launch vaccine by MarchThe Ahmedabad-based drug maker will submit the results of its phase-2 trials next week, which "will ascertain the safety, dose and efficacy...
- Cadila Healthcare Q2 results: Net profit jumps over four-fold to Rs 473.4 crConsolidated total revenue from operations of the company stood at Rs 3,820 crore for the quarter under consideration. It was Rs 3,366.6 cr...
- Zydus promise: Covid-19 vaccine by MarchThe Independent Data Safety Monitoring Board has reviewed the data and has found the vaccine to be safe.
- India seems to be getting closer to an antidote, even as the coronavirus situation worsensThis week India overtook the US in daily addition of new COVID-19 cases. It is worrying. The World Health Organization says that the infect...
- Zydus Cadila begins human trials of its COVID-19 vaccine, aims for an early 2021 launchThe company said in the preclinical stage the vaccine was found to be safe, immunogenic and well-tolerated. It was also able to produce neu...
Load More
